** = Publications listed in SCI/SSCI/Pubmed
** Kovacs, G; Avian, A; Bachmaier, G; Troester, N; Tornyos, A; Douschan, P; Foris, V; Sassmann, T; Zeder, K; Lindenmann, J; Brcic, L; Fuchsjaeger, M; Agusti, A; Olschewski, H
Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic Approach.
Chest. 2022; 162(1):202-212
Doi: 10.1016/j.chest.2022.01.031
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sassmann, T; Douschan, P; Foris, V; Tröster, N; Zeder, K; Brcic, L; Tornyos, A; Bachmaier, G; Fuchsjäger, M; Olschewski, H; Kovacs, G
Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD.
Respir Res. 2022; 23(1):331
Doi: 10.1186/s12931-022-02238-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Nagy, BM; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity.
Eur Respir J. 2020; 55(6):
Doi: 10.1183/13993003.01228-2019
Web of Science
PubMed
FullText
FullText_MUG
** Nagy, B; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
No indication of insulin resistance in idiopathic PAH with preserved physical activity.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1496
[Poster]
Web of Science
FullText
FullText_MUG
** Nagy, BM; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
No indication of insulin resistance in idiopathic PAH with preserved physical activity.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):619-619.
[Poster]
Web of Science
** Nagy, BM; Kovacs, G; Tornyos, A; Svehlikova, E; Foris, V; Nagaraj, C; Kwapiszewska, G; Pieber, TR; Olschewski, A; Olschewski, H
Is idiopathic pulmonary arterial hypertension caused by insulin resistance?
WIEN KLIN WOCHENSCHR. 2019; 131(19-20):526-526.
[Oral Communication]
Web of Science
** Oldham, WM; Oliveira, RKF; Wang, RS; Opotowsky, AR; Rubins, DM; Hainer, J; Wertheim, BM; Alba, GA; Choudhary, G; Tornyos, A; MacRae, CA; Loscalzo, J; Leopold, JA; Waxman, AB; Olschewski, H; Kovacs, G; Systrom, DM; Maron, BA
Network Analysis to Risk Stratify Patients With Exercise Intolerance.
Circ Res. 2018; 122(6):864-876
Doi: 10.1161/CIRCRESAHA.117.312482
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Nagy, B; Bordag, N; Nagaraj, C; Foris, V; Tornyos, A; Narath, S; Gander, E; Magnes, C; Kovacs, G; Klepetko, W; Pieber, TR; Kwapiszewska, G; Olschewski, H; Olschewski, A
Metabolic fingerprinting in pulmonary hypertension*
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):604-605.
[Oral Communication]
Web of Science
** Tornyos, A; Trinker, M; Foris, V; Pfeiffer, S; Odler, B; Douschan, P; Avian, A; Leitner, A; Olschewski, A; Kovacs, G; Olschewski, H
Pulmonary hypertension in hypersensitivity pneumonitis
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):621-621.-42. Jahrestagung der Österreichischen
Gesellschaft für Pneumologie
2. Jahrestagung der Österreichischen
Gesellschaft für Thoraxchirurgie; OCT 18-20; Linz, AUSTRIA.
[Poster]
Web of Science
** Tornyos, A; Trinker, M; Foris, V; Pfeiffer, S; Odler, B; Douschan, P; Avian, A; Leitner, A; Olschewski, A; Kovacs, G; Olschewski, H
Pulmonary hypertension in hypersensitivity pneumonitis.
EUR RESPIR J. 2018; 52: -28th International Congress of the European-Respiratory-Society (ERS); SEP 15-19, 2018; Paris, FRANCE.
Doi: 10.1183/13993003.congress-2018.PA3100
[Poster]
Web of Science
FullText
FullText_MUG
** Tornyos, A; Aradi, D; Horváth, IG; Kónyi, A; Magyari, B; Pintér, T; Vorobcsuk, A; Tornyos, D; Komócsi, A
Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity.
PLoS One. 2017; 12(12): e0188493
Doi: 10.1371/journal.pone.0188493
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Odler, B; Reiter, U; Reiter, G; Fuchsjaeger, M; Foris, V; Tornyos, A; Douschan, P; Olschewski, A; Olschewski, H; Kovacs, G
Cardiac magnetic resonance parameters in the assessment of pulmonary hemodynamics: a validation study
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):768-768.SEPT ; Milan, ITALY.
[Poster]
Web of Science
** Kupó, P; Aradi, D; Tornyos, A; Tőkés-Füzesi, M; Komócsi, A
Assessment of platelet function in patients receiving tirofiban early after primary coronary intervention.
Interv Med Appl Sci. 2016; 8(4): 135-140.
Doi: 10.1556/1646.8.2016.4.8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tornyos, A; Kehl, D; D'Ascenzo, F; Komócsi, A
Risk of Myocardial Infarction in Patients with Long-Term Non-Vitamin K Antagonist Oral Anticoagulant Treatment.
Prog Cardiovasc Dis. 2016; 58(5): 483-94.
Doi: 10.1016/j.pcad.2015.12.001
Web of Science
PubMed
FullText
FullText_MUG
** Odler, B; Douschan, P; Pfeiffer, S; Foris, V; Tornyos, A; Avian, A; Olschewski, A; Olschewski, H; Kovacs, G
Diffusion capacity for nitric oxide: a novel marker for pulmonary hemodynamics and exercise capacity?
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):768-768.
[Poster]
Web of Science
** Tornyos, A; Trinker, M; Foris, V; Pfeiffer, S; Odler, B; Douschan, P; Avian, A; Olschewski, A; Kovacs, G; Olschewski, H
Pulmonary hypertension in hypersensitivity pneumonitis
EUR RESPIR J. 2016; 48: -Annual Congress of European Respiratory Society; SEPT 3-7, 2016; London, UNITED KINGDOM.
Doi: 10.1183/13993003.congress-PA2450
[Poster]
Web of Science
FullText
FullText_MUG
** Tornyos, A; Vorobcsuk, A; Kupó, P; Aradi, D; Kehl, D; Komócsi, A
Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials.
J Thromb Thrombolysis. 2015; 40(1): 1-11.
Doi: 10.1007/s11239-014-1096-z
Web of Science
PubMed
FullText
FullText_MUG
** Aradi, D; Tornyos, A; Pintér, T; Vorobcsuk, A; Kónyi, A; Faluközy, J; Veress, G; Magyari, B; Horváth, IG; Komócsi, A
Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.
J Am Coll Cardiol. 2014; 63(11): 1061-70.
Doi: 10.1016/j.jacc.2013.12.023
Web of Science
PubMed
FullText
FullText_MUG
** Kiss, T; Kovacs, K; Komocsi, A; Tornyos, A; Zalan, P; Sumegi, B; Gallyas, F; Kovacs, K
Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt.
PLoS One. 2014; 9(8): e104890
Doi: 10.1371/journal.pone.0104890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Költő, G; Vuolteenaho, O; Szokodi, I; Faludi, R; Tornyos, A; Ruskoaho, H; Minier, T; Czirják, L; Komócsi, A
Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study.
Clin Exp Rheumatol. 2014; 32(6 Suppl 86): S-75-81.
PubMed
** Komócsi, A; Aradi, D; Kehl, D; Ungi, I; Thury, A; Pintér, T; Di, Nicolantonio, JJ; Tornyos, A; Vorobcsuk, A
Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Arch Med Sci. 2014; 10(2): 203-12.
Doi: 10.5114/aoms.2014.42570
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Komócsi, A; Tornyos, A; Kehl, D; Aradi, D; Vorobcsuk, A
Mortality after transradial approach in ST-segment elevation myocardial infarction. Do we see the forest for the trees?
Int J Cardiol. 2013; 168(3): 3050-3.
Doi: 10.1016/j.ijcard.2013.04.104
Web of Science
PubMed
FullText
FullText_MUG